Advisory Council on Rare Diseases and Personalized Medicine

Meeting information is retained on this page for 7 years then sent to the Missouri State Archives.

Register for Public Comment

Any interested party shall be granted the opportunity for clinically relevant public comment for up to five (5) minutes per medication under review by the DUR Board. The responsibility of scheduling the presentation shall rest with the interested party. Interested parties representing a manufacturer shall be granted five (5) minutes in the aggregate per medication under review by the DUR Board.